OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Relationship between the expressions of PD-L1 and tumour-associated fibroblasts in gastric cancer
Linsong Mu, Wentao Yu, Hailong Su, et al.
Artificial Cells Nanomedicine and Biotechnology (2019) Vol. 47, Iss. 1, pp. 1036-1042
Open Access | Times Cited: 21

Showing 21 citing articles:

PD-1/PD-L1 pathway: current researches in cancer.
Yanyan Han, Dandan Liu, Lianhong Li
PubMed (2020) Vol. 10, Iss. 3, pp. 727-742
Closed Access | Times Cited: 1375

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 71

The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment
Pan Zhang, Chao Qin, Nan Liu, et al.
Biomaterials (2022) Vol. 284, pp. 121518-121518
Closed Access | Times Cited: 42

JAK-STAT1 Signaling Pathway Is an Early Response to Helicobacter pylori Infection and Contributes to Immune Escape and Gastric Carcinogenesis
Xue Li, Kai‐Feng Pan, Michael Vieth, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4147-4147
Open Access | Times Cited: 33

Targeting GPC3 high cancer-associated fibroblasts sensitizing the PD-1 blockage therapy in gastric cancer
Dinuo Li, Yu Wang, Ce Shi, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 20

PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer
Kento Kawasaki, Kazuhiro Noma, Takuya Kato, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3787-3802
Open Access | Times Cited: 18

Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1
Wei Liu, Han Chen, Dongsheng Wang
Immunopharmacology and Immunotoxicology (2021) Vol. 43, Iss. 4, pp. 443-451
Closed Access | Times Cited: 39

Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation
Zhixin Tao, Chao‐Yuan Huang, Deqiang Wang, et al.
Experimental Cell Research (2023) Vol. 424, Iss. 1, pp. 113492-113492
Closed Access | Times Cited: 15

Overcoming chimeric antigen receptor-T (CAR-T) resistance with checkpoint inhibitors: Existing methods, challenges, clinical success, and future prospects: A comprehensive review
Kartik Tulsian, Dhruma Thakker, Vivek K. Vyas
International Journal of Biological Macromolecules (2025), pp. 141364-141364
Closed Access

PD-L1 testing in advanced gastric cancer—what physicians who treat this disease must know—a literature review
Renata D’Alpino Peixoto, Maria Cecília Mathias-Machado, Alexandre A. Jácome, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 3, pp. 1560-1575
Open Access | Times Cited: 9

Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma
Li Zhang, Mengmeng Song, Fan Zhang, et al.
Journal of Histochemistry & Cytochemistry (2020) Vol. 69, Iss. 3, pp. 165-176
Open Access | Times Cited: 22

Application of Traditional Chinese Medicine in Inhibiting the PD-1/PD-L1 Pathway in the Treatment of Gastric and Colon Cancers
Xinghui Zhu, ShuJie Wang, Lie Wen Xie, et al.
Natural Product Communications (2024) Vol. 19, Iss. 6
Open Access | Times Cited: 2

Extracellular Vesicle Mediated Tumor-Stromal Crosstalk Within an Engineered Lung Cancer Model
Kayla F. Goliwas, Hannah M. Ashraf, Anthony M. Wood, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 10

Factors correlating the expression of PD-L1
Fang Lu, Ernuo Wang, Haiquan Liu
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Association of PD-L1 Expression with Clinicopathologic Characters in Gastric Cancer: A Comprehensive Meta-analysis
Zhuo Han, Nan Wang, Qing Qiao, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 21, pp. 3198-3216
Closed Access | Times Cited: 3

Recent developments in PD-1/PD-L1 blockade research for gastroesophageal malignancies
Meng Chen, Chenyan Li, Mingjun Sun, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4

PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome
Kento Kawasaki, Kazuhiro Noma, Takuya Kato, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1

Cancer-Associated Fibroblasts in Gastric Cancer Regulate Macrophage Polarization through RCN3 Pathway
Lu Yang, Chang Zhou, Xin Zheng, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access

Mixed-type gastric carcinoma: classification, morphological diagnosis and prognosis of the disease
Л.М. Михалева, E. P. Akopyan, K.Yu. Midiber, et al.
Clinical Medicine (Russian Journal) (2020) Vol. 98, Iss. 3, pp. 197-202
Closed Access | Times Cited: 1

Decoding the Impact of Genetic Variants in Gastric Cancer Patients Based on High-Dimensional Copy Number Variation Data Using Next-Generation Knowledge Discovery Methods
Fehmida Bibi, Peter Natesan Pushparaj, Muhammad Imran Naseer, et al.
Applied Sciences (2022) Vol. 12, Iss. 19, pp. 10053-10053
Open Access

Page 1

Scroll to top